0709 203000 - Nairobi 0709 983000 - Kilifi
0709 203000 - NRB 0709 983000 - Kilifi
0709 203000 - NRB | 0709 983000 - Kilifi

Publications

Back Home

Epidemiology and Demography


740 results

A Pragmatic Trial of Glucocorticoids for Community-Acquired Pneumonia.Lucinde, R. K. Gathuri, H. Mwaniki, P. Orindi, B. Otieno, E. O. Mwakio, S. Mulemi, L. Isaaka, L. Shangala, J. Saisi, M. Isinde, E. Oginga, I. N. Wachira, A. W. Manuthu, E. Kariuki, H. Asaava, P. Nyikuli, J. Wekesa, C. Otedo, A. Bosire, H. Okoth, S. B. Ongalo, W. Mukabi, D. M. Lusamba, W. Muthui, B. Adembesa, I. Mithi, C. Sood, M. Aliyan, N. A. Gituma, B. Matiko, M. G. Omondi, C. A. Ombajo, L. A. Kirui, N. Ochola, L. Abdi, A. I. Kagucia, E. W. English, M. Hamaluba, M. Ochola-Oyier, I. Kamuya, D. Bejon, P. Barasa, E. Agweyu, A. Akech, S. Etyang, A. O.
N Engl J Med, (2025). 393:2187-2197

Plasma folate dynamics in Plasmodium falciparum-infected African children treated with artemisinin combination therapy and single low-dose primaquine or placebo.Ajayi, S. Onyamboko, M. A. Olupot-Olupot, P. Ayuen, D. S. Chimjinda, N. Taya, C. Williams, T. N. Uyoga, S. Maitland, K. Fanello, C. Day, N. P. J. Mukaka, M. Taylor, W. R. J.
Malar J, (2025). 24:342

Assessing the Impact of SARS-CoV-2 Spike Mutations on Antibody Binding: A Comparative Assessment of the Wuhan and JN.1 Variants' Full-Length Spikes in a Multiplex Luminex Assay.Waweru, G. Nyakundi, R. Kutima, B. Owuor, S. Konyino, G. Gitonga, J. Lugano, D. Maina, A. Musyoki, J. Ochola, L. Omondi, M. Kariuki, C. K. Ogongo, P. Mwachari, C. Shee, F. Agoti, C. Sande, C. Uyoga, S. Kagucia, E. Agweyu, A. Bejon, P. Scott, J. A. G. Warimwe, G. M. Ochola-Oyier, L. I. Nyagwange, J.
Viruses, (2025). 17:

Modelling the relative contribution of infection, routine vaccination and supplementary immunisation activities to measles seroconversion in Kenyan Children.Mburu, C. Ojal, J. Selim, R. Ombati, R. Akech, D. Karia, B. Tuju, J. Sigilai, A. Smits, G. Gageldonk, P. V. Klis, F. V. Kagucia, E. Scott, A. Adetifa, I. Flasche, S.
PLoS Comput Biol, (2025). 21:e1013531

Genomic and clinical epidemiology of SARS-CoV-2 in coastal Kenya: insights into variant circulation, reinfection, and multiple lineage importations during a post-pandemic wave.Lambisia, A. W. Katama, E. N. Moraa, E. Mwita, J. M. Gallagher, K. Mutunga, M. Nyale, E. Omungala, J. Mwanga, M. Murunga, N. Nyiro, J. Nyagwange, J. Sande, C. Bejon, P. Githinji, G. Dellicour, S. Phan, M. V. T. Cotten, M. Ochola-Oyier, L. I. Holmes, E. C. Agoti, C. N.
BMC Glob Public Health, (2025). 3:80

Cryptosporidium parvum virus 1 genome sequences from pediatric diarrhea cases in coastal Kenya.Agoti, C. N. Njeru, R. Mwanga, M. Mutunga, M. Shah, S. P. Chu, T. Y. Nokes, D. J. Cotten, M. Phan, M. V. T.
Microbiol Resour Announc, (2025). 14:e0034925

Epidemiological dynamics of influenza B virus across multiple seasons in Kenya and Uganda inferred from sequence data, 2010-2021.Nyarango, B. K. Owuor, D. C. Isoe, E. Mutunga, M. Cheruiyot, R. Katama, E. N. Makori, T. Lambisia, A. Nyiro, J. Githinji, G. Kiguli, S. Olupot-Olupot, P. Maitland, K. Agoti, C. N.
BMC Infect Dis, (2025). 25:1080

Perceived accuracy and utilisation of DHIS2 data for health decision making and advocacy in Kenya: A Qualitative Study.Oware, P. M. Omondi, G. Adipo, C. Adow, M. Wanyama, C. Odallo, D. Bosire, N. Okong'o, L. Maina, M. Aluvaala, J. Ngwatu, P. Githanga, D. Kinuthia, D. Amadi, I. Rukwaro, G. Kerubo, L. Amisi, C. Govoga, A. Karimi, J. Kahtra, A. Mulwa, A. Amoth, P. Agweyu, A. Were, F.
PLOS Glob Public Health, (2025). 5:e0004508

Retaining African networks is urgent for global health.Bhiman, J. N. Serwanga, J. Ugwu, C. A. Vigan-Womas, I. Quashie, P. K. Bhattacharya, J. Sande, C. Bonomo, A. Markey, F. B. Awandare, G. A. Garg, P. K. Kaleebu, P. Happi, C. Rennergarbe, A. Woods, C. Kirchner, J. Aguilar, A. O. Makar, K. Moore, P. L. Giiser network
Trends Microbiol, (2025). 33:1150-1154

The impact of 10-valent pneumococcal conjugate vaccine on the incidence of admissions to hospital with hypoxaemic and non-hypoxaemic pneumonia in Kenyan children.Haeusler, I. L. Kagucia, E. W. Bottomley, C. Otiende, M. Nyiro, J. Scott, J. A. G.
PLOS Glob Public Health, (2025). 5:e0004888

Addressing the challenges of estimating the target population in calculation of routine infant immunization coverage in Kenya.Karanja-Chege, C. Agweyu, A. Were, F. Boele van Hensbroek, M. Ogallo, W.
PLOS Glob Public Health, (2025). 5:e0004298

Implementing community-based interventions for the management of chronic conditions in low- and middle-income countries: A scoping review of qualitative evidence.Hassan, S. Kagwanja, N. Diallo, B. Oyando, R. Perel, P. Etyang, A. Tsofa, B. Nolte, E. I. HCoR-Africa Collaborators
PLOS Glob Public Health, (2025). 5:e0004860

Lessons learnt during establishment of COVID-19 active vaccine safety surveillance in nine African countries.Cutland, C. L. Gutu, K. Yun, J. A. Izu, A. Mahtab, S. Peter, J. Ansah, N. A. Obaro, S. Tilahun, B. Jambo, K. Sow, S. Kagucia, E. W. Chicumbe, S. Dlamini, T. Browne, M. Clothier, H. Griffin, J. Jiang, Y. Lee, A. Ghebreab, L. Madhi, S. A. Black, S. B. Active vaccine safety surveillance, team
Vaccine, (2025). 62:127441

Trials for LLM-supported clinical decisions in African primary healthcare.Mateen, B. A. Menon, V. Agweyu, A. Korom, R. Omoluabi, E. McAfee, D. Shimelash, N. Rutunda, S. Rugege, C. Williams, G. Emmanuel-Fabula, M. Denniston, A. K. Liu, X. Miles, M.
Nat Med, (2025). 31:2833-2835

Single low dose primaquine to block the transmission of Plasmodium falciparum-proposed stand-alone and ACT-adapted regimens.Taylor, W. R. J. Olupot-Olupot, P. Onyamboko, M. A. Chimjinda, N. Taya, C. Pouplin, J. N. N. Williams, T. N. Maitland, K. Fanello, C. A. Day, N. P. J. Tarning, J. White, N. J. Mukaka, M.
BMC Med, (2025). 23:397

Early weaning from oxygen therapy in African children with severe pneumonia.Maitland, K. Giallongo, E. Hamaluba, M. Alaroker, F. Opoka, R. O. Tagoola, A. Nalwanga, D. Nabawanuka, E. Okiror, W. Nakuya, M. Aromut, D. Williams, T. N. Thomas, K. Harrison, D. A. Mouncey, P. Bush, A. Fraser, J. F. Rowan, K. Olupot-Olupot, P. Kiguli, S. Coast trial group
BMC Med, (2025). 23:366

GRAPEVNE - Graphical Analytical Pipeline Development Environment for Infectious Diseases.Brittain, J. S. Tsui, J. Inward, R. Gutierrez, B. Mwanyika, G. Tegally, H. Huynh, T. Githinji, G. Tessema, S. K. McCrone, J. T. Bhatt, S. Dasgupta, A. Ratcliffe, S. Kraemer, M. U. G.
Wellcome Open Res, (2025). 10:279

Emergence and transmission dynamics of the FY.4 Omicron variant in Kenya.Musundi, S. Mwanga, M. Lambisia, A. Morobe, J. M. Murunga, N. Moraa, E. Ndwiga, L. Cheruiyot, R. Musyoki, J. Mutunga, M. Guzman-Rincon, L. M. Sande, C. Mwangangi, J. Bejon, P. Ochola-Oyier, L. I. Nokes, D. J. Agoti, C. N. Nyiro, J. Githinji, G.
Virus Evol, (2025). 11:veaf035

Deploying Metagenomics to Characterize Microbial Pathogens During Outbreak of Acute Febrile Illness Among Children in Tanzania.Mziray, S. R. Githinji, G. de Laurent, Z. R. Mbelele, P. M. Mohammed, K. S. Wadugu, B. D. Grundy, B. S. Heysell, S. K. Mpagama, S. G. Chilongola, J. O.
Pathogens, (2025). 14:

Seroprevalence of Immunoglobulin G against measles and rubella over a 12-year period (2009-2021) in Kilifi, Kenya and the impact of the Measles-Rubella (MR) vaccine campaign of 2016.Mburu, C. N. Ojal, J. Selim, R. Ombati, R. Akech, D. Karia, B. Tuju, J. Sigilai, A. Smits, G. van Gageldonk, P. G. M. van der Klis, F. R. M. Flasche, S. Kagucia, E. W. Scott, J. A. G. Adetifa, I. M. O.
Vaccine, (2025). 61:127425